Your browser doesn't support javascript.
loading
Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells.
Chen, Rong; Chen, Yuling; Xiong, Ping; Zheleva, Daniella; Blake, David; Keating, Michael J; Wierda, William G; Plunkett, William.
Afiliação
  • Chen R; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen Y; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Xiong P; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zheleva D; Cyclacel Pharmaceuticals Inc, Dundee, UK.
  • Blake D; Cyclacel Pharmaceuticals Inc, Dundee, UK.
  • Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Plunkett W; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. wplunket@mdanderson.org.
Leukemia ; 36(6): 1596-1608, 2022 06.
Article em En | MEDLINE | ID: mdl-35383271

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos